After undergoing prenatal heart surgery at just 24 weeks of gestation while still in his mother’s womb, Tucker Roussin, now 3 years old, is alive and doing well.

After five years of follow-up, patients with coronary artery disease had similar rates of the composite outcome of death, stroke, MI, renal failure or repeat revascularization whether they underwent off-pump or on-pump CABG, according to a randomized trial.

According to the Centers for Disease Control and Prevention (CDC), more than half a million patients who underwent open-heart surgery since 2012 could have been exposed to a type of nontuberculosis mycobacteria (NTM).

The U.S. prosthetic heart valve market is expected to reach $6.3 billion by the end of 2016, according to a new report from Future Market insights, a New York-based market intelligence and consulting firm.

Stealth BioTherapeutics' phase 2 study examines whether treatment for myocardial dysfunction will relieve congestive heart failure.  

HeartWare recalled some of its HVAD ventricular assist device pumps due to a design problem that could cause serious adverse events, including death.

Patients who adhered to their medical therapy for up to eight years after undergoing CABG or PCI had significantly fewer major adverse cardiac events compared with those who did not adhere to their treatment, according to a retrospective, observational study.

The stethoscope may be on its last legs—and this could mean trouble for patients.